Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2006	FY 2005
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Market Cap	228	263	174	296	-	-
Market Cap Growth	58.47%	51.21%	-41.18%	-	-	-
Enterprise Value	191.09	226.27	166.68	313.43	0	0
Last Close Price	6.61	7.70	6.32	11.22	-	-
PE Ratio	-	-22.65	-316.00	-18.70	-	-
Forward PE	53.87	15.88	-	90.85	-	-
PS Ratio	5.10	5.89	3.66	13.92	-	-
PB Ratio	6.43	7.42	-29.63	-25.45	-	-
P/TBV Ratio	5.33	6.20	-29.38	-25.65	-	-
P/FCF Ratio	-	-21.09	6.45	-17.25	-	-
P/OCF Ratio	-	-21.09	6.45	-17.25	-	-
EV/Sales Ratio	4.28	5.07	3.51	14.75	-	-
EV/EBITDA Ratio	-	-36.02	64.90	-24.54	-	-
EV/EBIT Ratio	-	-36.02	64.90	-24.54	-	-
EV/FCF Ratio	-	-18.14	6.18	-18.28	-	-
Debt / Equity Ratio	-	0	-3.29	-2.66	-	-
Debt / EBITDA Ratio	-	-	7.53	-2.42	-	-
Debt / FCF Ratio	-	-	0.72	-1.81	-	-
Net Debt / Equity Ratio	-1.04	-1.04	1.24	-1.52	-	-
Net Debt / EBITDA Ratio	5.86	5.86	-2.84	-1.38	-	-
Net Debt / FCF Ratio	2.95	2.95	-0.27	-1.03	-	-
Asset Turnover	0.77	0.77	1.32	0.79	-	-
Inventory Turnover	2.87	2.87	1.98	0.58	-	-
Quick Ratio	5.71	5.71	5.71	2.92	-	-
Current Ratio	6.37	6.37	6.38	3.56	-	-
Return on Equity (ROE)	-65.82%	-65.82%	4.98%	138.06%	-	-
Return on Assets (ROA)	-11.00%	-11.00%	43.92%	-47.54%	-	-
Return on Invested Capital (ROIC)	-36.15%	-36.15%	178.13%	-210.64%	-	-
Return on Capital Employed (ROCE)	-12.81%	-12.81%	8.96%	-66.13%	-	-
Earnings Yield	-4.27%	-4.42%	-0.32%	-5.35%	-	-
FCF Yield	-	-4.74%	15.51%	-5.80%	-	-
Buyback Yield / Dilution	-4.70%	-4.70%	-2.71%	-	-	-
Total Shareholder Return	-4.70%	-4.70%	-2.71%	-	-	-

Updated Mar 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q